Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOOTCELL: alloADSC-DFU-RL in Diabetic Foot Syndrome
NCT06843122Phase 2Recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Mar 2025
- Primary completion
- Feb 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic foot ulcer (DFU) (3 arms), sponsored by Medical University of Warsaw. Primary endpoints: Change in wound size at 6 weeks and Adverse Events at 6 weeks. Started Mar 2025; status: recruiting.
02
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06843122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06843122.